Earnings Preview: Supernus Pharmaceuticals (SUPN) Q4 Earnings Expected to DeclineZacks Investment Research • 02/17/26
Supernus Pharmaceuticals to Announce Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 24, 2026GlobeNewsWire • 02/12/26
Supernus Stock Is Up 31% This Past Year but Still 20% Below 2018 Highs as One Fund Scales BackThe Motley Fool • 12/16/25
Supernus Pharmaceuticals, Inc. (SUPN) Presents at BofA Securities CNS Therapeutics Virtual Conference 2025 TranscriptSeeking Alpha • 12/08/25
Supernus Pharmaceuticals to Participate in the Bank of America Securities 2025 CNS Therapeutics Virtual ConferenceGlobeNewsWire • 12/03/25
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare ConferenceGlobeNewsWire • 11/21/25
Supernus to Participate in the 2025 Jefferies Global Healthcare Conference in LondonGlobeNewsWire • 11/12/25
Supernus (SUPN) Reports Q3 Earnings: What Key Metrics Have to SayZacks Investment Research • 11/05/25
Supernus Pharmaceuticals (SUPN) Surpasses Q3 Earnings and Revenue EstimatesZacks Investment Research • 11/04/25
Here's Why Supernus Pharmaceuticals (SUPN) is a Great Momentum Stock to BuyZacks Investment Research • 10/29/25
Supernus Pharmaceuticals, Inc. (SUPN) Hits Fresh High: Is There Still Room to Run?Zacks Investment Research • 10/27/25
Supernus Pharmaceuticals to Announce Third Quarter 2025 Financial Results and Host Conference Call on November 4, 2025GlobeNewsWire • 10/21/25
Supernus Pharmaceuticals (SUPN) Is Up 2.81% in One Week: What You Should KnowZacks Investment Research • 10/13/25
Are You Looking for a Top Momentum Pick? Why Supernus Pharmaceuticals (SUPN) is a Great ChoiceZacks Investment Research • 09/25/25
Supernus Pharmaceuticals, Inc. (SUPN) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 09/23/25
Supernus (SUPN) Q2 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 08/06/25
Supernus Pharmaceuticals (SUPN) Surpasses Q2 Earnings and Revenue EstimatesZacks Investment Research • 08/05/25